![Walking Manhattan to Find a Cure](https://cmtrf.org/wp-content/uploads/2024/04/1-1080x675.png)
![Walking Manhattan to Find a Cure](https://cmtrf.org/wp-content/uploads/2024/04/1-1080x675.png)
The Importance of Fundraising
By: Miron Hall Because CMT is a rare disease, it often receives less attention and funding than more common medical conditions. Without adequate resources, researchers struggle to develop effective treatments and ultimately find a cure. This is where fundraising plays...![ARM-101: A Potential “Precision Drug Therapy” For CMT1A](https://cmtrf.org/wp-content/uploads/2023/10/Armatus-logo-RGB_May-1-1080x624.jpg)
ARM-101: A Potential “Precision Drug Therapy” For CMT1A
The CMT Research Foundation has invested in a project at Armatus Bio, Inc. that will advance a novel miRNA gene therapy candidate for CMT type 1A. Principal Investigator Dr. Brian Price and his colleagues aim to harness the potential of microRNAs (miRNAs), snippets of...![Arthur Suckow, former Co-founder and Chief Executive Officer of DTx Pharma, Joins CMT Research Foundation Board of Directors](https://cmtrf.org/wp-content/uploads/2023/10/Cleary-Edritz-Susan-Artie-1080x675.jpg)